GlyCare™ LNnT

GlyCare™ Lacto-N-neotetraose

LNnT is one of the most abundant neutral core HMO in human milk (1). 

Our HMOs are available in different forms including powders and tablets. Continue reading below to learn more about the exciting clinical and preclinical data for infants and children, or click Partner with us to talk with us about your product today. 

Immunity and Infections

Clinical studies have reported a relationship between HMOs and some immune outcomes in infants. Emerging science suggest that specific HMOs at the correct level of supplementation may help to reduce the risk of certain infections in infants consuming infant formula. 

A clinical trial supplementing LNnT plus 2’FL in infant formula was reported to help support the immune system of infants.  The results included a reduction in the incidence of certain (parent-reported) infections and illnesses. Also reported were significantly fewer lower respiratory tract infections; and a significant reduction in the use of anti-fever medication, and antibiotic use during the first 12 months of life (1). 

Gut Health and Microbiota

HMO reserch (preclinical and clinical data) report that HMOs may help to stimulate the growth of beneficial bacteria, which are believed to be important for development of the microbiota and gut health in infants. 

A clinical trial of infant formula supplemented with LNnT and 2’FL reported an increase in the population of bifidobacteria and an infant fecal microbiota more closely resembling that of a breast fed infant. Moreover the LNnT and 2’FL supplemented group was also reported to bring the intestinal microbiota of those infants born by C-section closer to that observed in infants born vaginally from the control group (3). At 2 months of age significantly softer stools were reported in the 2’FL+ LNnT group (2). 

Emerging science from preclinical study data may also indicate a role for LNnT alone in the growth of beneficial bacteria (4,5,6) and gut health (7,8).

Allergy Development

Emerging data from pre-clinical models and breast milk studies suggest that HMOs may play a role reducing the incidence of certain allergic manifestations.


An extensively hydrolyzed whey-based formula containing 2’FL and LNnT has been shown to be hypoallergenic.

An extensively hydrolyzed whey-based formula containing 2’FL and LNnT met the AAP criteria for hypoallergenicity.

Note that hypoallergenicity at levels above those studied (1.0 g/L and 0.5 g/L) may need to be assessed.


1. Puccio, G. et al., (2017). Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial.  JPGN 64: 624-31.

2. Berger, B et al., (2020). Linking human milk oligosaccharides, infant fecal community types, and later risk to require antibiotics.  mBio 11: e03196-19.

3. Miwa, M., Horimoto, T., Kiyohara, M., Katayama, T., Kitaoka, M., Ashida, H., & Yamamoto, K. (2010). Cooperation of β-galactosidase and β-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology, 20(11), 1402–1409. 

4. Marcobal, A., Barboza, M., Sonnenburg, E. D., Pudlo, N., Martens, E. C., Desai, P., … Sonnenburg, J. L. (2011). Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host and Microbe, 10(5), 507–514. 

5. Boler, B. M. V., Serao, M. C. R., Faber, T. a, Bauer, L. L., Chow, J., Murphy, M. R., & Fahey, G. C. (2013). In Vitro Fermentation Characteristics of Select Nondigestible. Journal of Agricultural and Food Chemistry, 61, 2109–2119.

6. Knol, C. (2018). Cross-feeding between Bifidobacterium infantis and Anaerostipes caccae on lactose and human milk oligosaccharides. BioRxiv.

7. Hester, S. N., & Donovan, S. M. (2012). Individual and Combined Effects of Nucleotides and Human Milk Oligosaccharides on Proliferation, Apoptosis and Necrosis in a Human Fetal Intestinal Cell Line. Food and Nutrition Sciences, 03(11), 1567–1576. 

HMO Health Benefit Solutions

Human Milk Oligosaccharides may support a number of health benefits such as immunity and gut health in early life.

More than ingredients

Learn how dsm-firmenich can help your business. Select the options below to connect your needs with the right solution.

I'd like to explore...

Quick Links

Premix Solutions

Customized blends of desired functional ingredients in one single, efficient, homogenous premix. 

Health Benefits & Solutions

Solutions to address consumers' health and lifestyle needs.

Market-ready Solutions

Streamline your product development process and get to market faster.

We're innovators in nutrition, health, and beauty. And we bring progress to life! 

Talking Nutrition

Explore new science, consumer insights, industry events and more.

Customer Portal

Request samples, place orders and view product documentation.